You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
復星醫藥(600196.SH):復鋭醫療科技擬配股淨籌6.15億港元

格隆匯7月20日丨復星醫藥(600196.SH)公佈,公司控股子公司Sisram(復鋭醫療科技)根據其股東大會授予的配發股份的一般性授權,於2021年7月19日與配售代理簽訂配售協議,根據協議約定,配售代理將按最佳努力基準以25.90港元/股的配售價,向不少於6名承配人配發最多2400萬股配售股份。

若該次配售所涉2400萬股Sisram(復鋭醫療科技)配售股份均獲發行,該次配售募得款項共約6.22億港元,預計該次配售所得款項淨額(扣減所有相關成本及開支,包括佣金及法律費用)約為6.15億港元,擬用於Sisram集團業務發展、渠道拓展等。

該次配售所涉2400萬股Sisram(復鋭醫療科技)配售股份均獲發行,預計公司(通過控股子公司美中互利醫療有限公司及能悦有限公司)合計持有的Sisram(復鋭醫療科技)股權比例將由截至公吿日的約74.76%減少至約70.91%該次配售尚須待達成若干先決條件後方可作實。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account